|
A comparative study on the efficacy and safety of intravenous lanatoside C, dilti- azem and amiodarone in patients with atrial fibrillation of rapid ventricular rate
2012, 40 (11):
157-1159 .
Abstract 0bjective: To evaluate the efficacy and safety of intravenous lanatoside C, diltiazem and amiodarone for controlling rapid ventricular rate in patients with atrial fibrillation(AF) in gerontal patient.Methods: 97 AF elderly patients(over 60 year old) with rapid atrial ventricular rate(≥120 beats/min) were randomly divided into 3 groups, the lanatoside C group(30 cases), group diltiazem(32 subjects) and group amiodarone (35 patients).The heart rate, blood pressure, rhythm were recorded before treatment, at 5, 10, 15, 30, 60 and 90 min after treatment.The reacting time,side effects including hypotension, bradyeardia, nausea, vomiting, dizziness, etc, were analyzed. Results: lanatoside C, diltiazem and amiodarone are equally safe and effective on controlling rapid ventricular rate in elderly patients with atrial fibrillation and total effective rate were 75%,90% and 85%. With the mean time response to the bolus was(35.4±15.7)min,(9.7±3.6)min and(18.8±7.6)min, respectively.In lanatoside C group , sinus rhythm was restored in 6 patients and asymptomatic hypotension developed in 1 patient. In diltiazem group, sinus rhythm was restored in 5 patients, asymptomatic hypotension developed in 2 patients and sinus bradycardia developed in 1 patient. In amiodarone group, sinus rhythm was restored in 8 patients and sinus bradycardia developed in 1 patient. All events were resolve without pharmacologic treatment. No patient developed worsening of congestive heart fililure due to lanatoside C, diltiazem and amiodarone. Conclusion: compared with lanatoside C, diltiazem and amiodarone are safe and effective in acutely 1owing of rapid ventricular rate in patients with atrial fibrillation. but diltiazem is more rapid and amiodarone is relatively safe in controlling AF with rapid ventricular response.
Related Articles |
Metrics
|